Ocean Biotech (003017.SZ) plans to build a product structure with rich potassium carbonate production capacity in stages of 500 million yuan

Zhitong Finance App News, Ocean Biotech (003017.SZ) announced that it plans to sign a “Potassium Hydroxide Product Supply and Demand Strategic Cooperation Agreement” with Shandong Yarong Chemical Co., Ltd. to expand production capacity for potassium carbonate products through a wholly-owned subsidiary to build new material projects with an annual output of 60,000 tons of potassium hydroxide lightweight potassium carbonate and 30,000 tons of fluidized bed heavy potassium carbonate, using the supporting advantages of Shandong Yarong Chemical Co., Ltd.'s potassium hydroxide industry and stable supply of carbon dioxide in the park. The project plans to invest 500 million yuan. The company plans to establish a wholly-owned subsidiary, Shandong Dayang New Materials Co., Ltd. (tentative name), in Ningyang Chemical Industrial Park, Shandong, as the main investor in this project.

The first phase of the project built a production line using liquid potassium hydroxide as a raw material to produce lightweight potassium carbonate through carbon dioxide carbonization, centrifugal separation, and calcination. The construction includes plants such as carbonization workshops, calcination workshops, crushing workshops, finished product warehouses, accessories warehouses, power plants (electricity distribution and water supply); liquid tank areas; pipe racks; sewage stations; office and living rooms, etc.

According to the announcement, after the foreign investment and construction project is put into operation, it will significantly increase the company's total production capacity of potassium carbonate, enrich the product structure, and accurately match the differentiated needs of high-end fields such as medicine, food, and electronics.